Respiratory Disorders To Upscale The Demand For Interventional Pulmonology

With lung cancer screening programs witnessing an upsurge across majority of the economies, interventional pulmonologists are bound to collaborate at an extensive level with medical oncologists for ascertaining patient’s quality of life (QOL). This factor is bound to keep the interventional pulmonology market on the toes in the forecast period – Persistence Market Research.

Interventional Pulmonology market is dispensed as….

Product-wise, the global interventional pulmonology market spans ENB (Electromagnetic Navigation Bronchoscopy), IP diagnostic devices (bronchoscopes (rigid and flexible), EBUS, aspiration needles, biopsy forceps, pleuroscopes (rigid and semi-flexible), and others), and IP therapeutic devices (endobronchial valves, pleural drainage catheters, endobronchial ablation systems, and airway stents). Indication-wise, it’s asthma, lung cancer, foreign body extraction, and tracheal and bronchial stenosis. End-user-wise, it’s ASCs (Ambulatory Surgical Centers), diagnostic centers, pulmonology clinics, and hospitals, biopharmaceutical shops.

Out of these, asthma and lung cancer hold the largest market share in terms of end-user. Coming to IP diagnostic devices, the flexible and semi-flexible versions are preferred over the rigid ones due to the convenience and harmlessness involved.

How about region-wise analysis?

North America holds the largest market share due to sizable spending by the US government on healthcare. As per CMS (Centers for Medicare and Medicaid Services), there is an increase of close to 4% in healthcare spending in the US every single year. Plus, the fact that around 8.3% of children below 18 years of age in the US do get infected with asthma is there to offer lucrative opportunities for interventional pulmonology market. Europe stands second on this count. However, the Asia-Pacific is expected to grow at the fastest rate in the interventional pulmonology market with establishment of NHRM (National Rural Health Mission) for enhancing rural healthcare in the countries like India. As far as LATAM is concerned, Mexico has gone for public-private partnership to improve medical devices and healthcare infrastructure.

The baton held by the Competitors

The key players in the interventional pulmonology market include Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Smiths Group Plc, Cook Medical Vygon, Clarus Medical LLC, Huger Medical Instrument Co. Ltd., Taewoong Medical Co. Ltd., Shanghai AoHua Photoelectricity Endoscope Co., Ltd., Karl Storz, Richard Wolf Corporation, and PENTAX Medical.

PENTAX is riding on its acquisition of C2 Therapeutics (US), thereby improving on its repair and aftersales services.

In all, the interventional pulmonology market would be growing on a stupendous note in wake of interventional pulmonologists putting their best foot forward to combat contraction of new-fangled infections – Persistence Market Research